The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (Remicade) and rituximab (Rituxan) – block triggers of inflammation. Biologics may be used alone or in combination with a traditional DMARD to treat autoimmune forms of arthritis, such as RA juvenile idiopathic arthritis (JIA), ankylosing spondylitis or psoriasis/psoriatic arthritis. Biologics are given as an injection or infusion, and as such, there is always a risk of an injection site reaction or an infusion reaction.
This report contains market size and forecasts of Anti-inflammatory Biologics in global, including the following market information:
Global Anti-inflammatory Biologics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anti-inflammatory Biologics Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Anti-inflammatory Biologics companies in 2021 (%)
The global Anti-inflammatory Biologics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Synthetic Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-inflammatory Biologics include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Sun Pharmaceutical Industries Ltd and Sanofi and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-inflammatory Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-inflammatory Biologics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Anti-inflammatory Biologics Market Segment Percentages, by Type, 2021 (%)
Synthetic Type
Biological Type
Global Anti-inflammatory Biologics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Anti-inflammatory Biologics Market Segment Percentages, by Application, 2021 (%)
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Global Anti-inflammatory Biologics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Anti-inflammatory Biologics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-inflammatory Biologics revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anti-inflammatory Biologics revenues share in global market, 2021 (%)
Key companies Anti-inflammatory Biologics sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Anti-inflammatory Biologics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Sun Pharmaceutical Industries Ltd
Sanofi
GlaxoSmithKline